Keywords: ERA; environmental risk assessment; EMA; European Medicines Agency; OECD; Organisation for Economic Co-operation and Development; EU; European Union; API; active pharmaceutical ingredient; GMO; genetically modified organism; VMP; veterinary medicinal prod
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: CT; computed tomography; PD; progression disease; ER; estrogen receptor; PR; progesterone receptor; EMA; epithelial membrane antigen; SMA; smooth muscle actin; UPS/MFH; undifferentiated pleomorphic sarcoma/malignant fibrous histiocytoma; US; undifferentia
Keywords: EMA; epithelial membrane antigen; Cervical vagus nerve schwannoma; Inter-capsular resection; Vagus nerve;
Keywords: AED; antiepileptic drug; AGA; anti-gliadin antibody; EMA; endomysial antibody; HLA; human leukocyte antigen; MRI; magnetic resonance imaging; NAA/Cr; N-acetyl aspartate:creatine ratio; PHT; patients without clinical evidence of ataxia; PHTA; patients with
Keywords: EMA; ecological momentary assessment; NA; negative affect; PA; positive affect; PANAS; positive-affect negative-affect schedule; Marijuana use; Adolescents; Young adults; Events; Affect;
Keywords: Relapse prevention; EMA; Ecological momentary assessment; Substance use disorder; Recovery;
Keywords: Clinical trial; Pilot; Training concept; Pharmacokinetic; Pharmacodynamic; Feasibility; ACE; Angiotensin-converting-enzyme; Cmax; maximum serum concentration; ELISA; Enzyme-linked immunosorbent assay; EMA; European Medicines Agency; EU; European Union; FD
Keywords: Vildagliptin; Drug-induced liver injury; Hypersensitivity; Covalent binding; Nucleophilic trapping agents; ALG; alogliptin; ANG; anagliptin; CRP; C-reactive protein; CYP; cytochrome P450; DILI; drug-induced liver injury; DLST; drug-induced lymphocyte stim
Keywords: NIR; Near-infrared; EMA; European Medicines Agency; GMP; Good Manufacturing Practice; ICH; International Council for Harmonization; API; Active Pharmaceutical Ingredients; NapSo; Naproxen Sodium; PLS; Partial Least Square; Cellulose; Microcrystalline Cell
Keywords: Biotherapeutics; Gene and cell therapy; Pharmacokinetics; Non-clinical safety; Immunogenicity; Cross-reactive species; ATMP; advanced therapy medicinal products; CAR; chimeric antigen receptor; CD; cluster of differentiation; CMC; chemistry manufacturing
Keywords: 2D-LC; Two Dimensional Liquid Chromatography; ADC; Antibody Drug Conjugate; AEX; Anion Exchange Chromatography; BEH; Bridged Ethylene Hybrid (hybrid silica); BSA; Bovine Serum Albumin; BsAb; Bispecific Antibody; CQA; Critical Quality Attribute; EMA; Europ
Keywords: ADD; animal daily dose; ADDD; animal defined daily dose; AMR; antimicrobial resistance; CASP; critical appraisal skills programme; DADD; defined animal daily dosage; DDD; defined daily dose; DDDA; daily doses animal; DDDvet; defined daily dose; DCDvet; de
Keywords: NSCLC; Non-Small Cell Lung Carcinoma; SCLC; Small Cell Lung Carcinoma; AC; Adenocarcinoma; LCT; Lung Carcinoid Tumor; LCC; Large Cell Carcinoma; CTC; Circulating Tumor Cells; UICC; The Union for International Cancer Control; CT; Computer-based Tomography;
Keywords: 5-FU; 5-fluorouracil; AF; atrial fibrillation; ALK; anaplastic lymphoma kinase; APD; action potential duration; APL; acute promyelocytic leukemia; BCR-ABL; breakpoint cluster region-Abelson; BTK; Bruton tyrosine kinase; CD20; cluster of differentiation 20
Keywords: ACN; acetonitrile; AD; antidepressant; AP; antipsychotic; CAL; calibration; R2; coefficient of determination; CV; coefficient of variation; CE; collision energy; cpd; compound of interest; CI; confidence interval; dMRM; dynamic multiple reaction mode; ESI
Keywords: Vowel undershoot; Diphthong; Inter-speaker variation; Gender-specific differences; Acoustic-articulatory relationship; German; EMA;
Keywords: CV; coefficient of variation; CS; calibration standard; DMSO; dimethylsulfoxide; EMA; European Medicine Agency; FDA; Food and Drug Administration; GCP; Good Clinical Practice; GLP; Good Laboratory Practice; IS; internal standard; K3EDTA; tripotassium ethy
Keywords: European regulation model; HMP; EU monograph; TUR; WEU-MA; ESCOP; European Scientific Cooperative on Phytotherapy; WHO; World Health Organization; EU; European Union; HMPs; herbal medicinal products; WEU-MAs; marketing authorizations; TURs; traditional us
Keywords: Japanese; Vowel devoicing; Articulatory phonetics; EMA; Phonetic interpolation; Gestural coordination; CV timing;
Keywords: Histopathology; Immunohistochemistry; Malignant mesothelioma; Spinal tumor; Surgical resection; EMA; Epithelial membrane antigen; HMGB1; High-Mobility Group Box Protein 1; MRI; Magnetic resonance imaging; SUVmax; Maximum standardized uptake value;
Keywords: DOAC; direct oral anticoagulant; EMA; European Medicines Agency; FDA; Food and Drug Administration; IS; internal standard; SPE; solid phase extraction; (UP)LC/MS/MS; (ultra-performance) liquid chromatography coupled to tandem mass spectrometry; QC; qualit
Keywords: Psychosis; Negative symptoms; Asociality; ESM; EMA;
Keywords: ABD3; albumin-binding domain 3; ACN; acetonitrile; AUC; area under the curve; BA; bioavailability; cAMP; cyclic adenosine monophosphate; CHO; Chinese hamster ovary; DIEA; diisopropyl ethylene diamine; Cmax; peak plasma concentration; CLp; plasma clearance
Keywords: EE; (Ethylmalonic encephalopathy); H2S; (hydrogen sulfide); EMA; (ethylmalonic acid); DHA; (dehydroascorbic acid); COX; (cytochrome c oxidase); NAC; (N-acetylcysteine); SCAD; (Short-chain acyl-CoA dehydrogenase);
Keywords: HS; Human serum; FBS; Fetal bovine serum; HPV; Human papillomavirus; DT; Doubling time; STR; Short Tandem Repeat; poly-HEMA; poly-(2-hydroxyethyl methacrylate); SD; Standard deviation; FDA; Food and drug administration; EMA; European Medicines Agency; GCC
Keywords: Relapse prevention; EMA; Ecological momentary assessment; Substance use disorder; Recovery;
Keywords: Family medicine; Phytomedicine; Phytotherapy; Traditional herbal medicines; Medical education; AIDS; acquired immunodeficiency syndrome; CAM; complementary and alternative medicine; EAS; European advisory services; EC; European commission; EMA; European m
Keywords: Support for quitting; Smoking cessation; Expectancy violation; Ecological momentary assessment; EMA; Response surface analysis;
Keywords: T2DM; type 2 diabetes; IR; insulin resistance; HbA1c; glycated hemoglobin A1c; GLUT-4; glucose transporter4; GLP-1; glucagon-like peptide-1; DPP4; dipeptidyl peptidase; eGFR; estimated glomerular filtration rate; HF; heart failure; UKPDS; United Kingdom P
Keywords: fHb; free hemoglobin; EMA; European Medicines Agency; HEBI-Fit; Hemoglobin Bilirubin Fit; QC; Quality control; CV; Coefficient of variation; LLOQ; Lower limit of quantification; ULOQ; Upper limit of quantification;
Keywords: RASFF; EMA; MedISys; HorizonScan; Food adulteration;
Keywords: AF; activation functions; BZA; bazedoxifene; CE; conjugated estrogens; E2; 17β-estradiol; E3; estriol; E4; estetrol; EDC; estrogen dendrimer conjugate; EE; ethinylestradiol; EMA; European Medicines Agency; ER; estrogen receptor; FDA; Food and Drug Admini
Keywords: ANDA; Abbreviated New Drug Application; API; Active Pharmaceutical Ingredient; BA; Bioavailability; BE; Bioequivalence; BCS; Biopharmaceutics Classification System; CES; Clinical Endpoint Studies; CRS; Confocal Raman Spectroscopy; DMK; Dermatopharmacokine
Keywords: API; active pharmaceutical ingredient; BD; bulk density; CGMPs; current good manufacturing practices; CI; Carr Index; CQAs; critical quality attributes; DoE; design of experiments; EMA; European medicines agency; FDA; food and drug administration; GKF; ge
Keywords: Characterization; Nanomedicine; Regulatory; Biological systems; Quality control; AFM; Atomic force microscopy; API; Active pharmaceutical ingredient; BSAI; Biological Surface Adsorption Index; CARPA; Complement activation related pseudo allergy; CRO; Cont
Keywords: Asp-N; endoproteinase AspN; BLA; biologics license application; CDR; complementarity determining region; CFR; Code of Federal Regulations; CGF; carboxyl group footprinting; cGMP; current good manufacturing practice; CHO; Chinese hamster ovary; CID; collis
Keywords: ADA; anti-drug antibodies; CHMP; Committee for Medicinal Products for Human Use; DIN; Drug Identification Number; ECCO; European Crohn's and Colitis Organisation; EMA; European Medicines Agency; FDA; Food and Drug Administration; INN; International Nonp
Keywords: ALK1; activin receptor-like kinase1; ANG/Ang; angiopoietin; Bcl-xL; b-cell lymphoma-extra large; BM; bone marrow; BMDCs; bone marrow derived cells; BMP; bone morphogenetic protein; Bv8; bombina variagata peptide 8; CAFs; cancer/carcinoma associated fibrob
Keywords: FTN; full-term newborns; PA; perinatal asphyxia; HIE; hypoxic-ischemic encephalopathy; CP; cerebral palsy; H-I; hypoxic-ischemic insult; CNS; central nervous system; BM; biomarkers; GFAP; glial fibrillary acidic protein; NSE; neuron specific enolase; AM;
Keywords: IEES; intradural extramedullary Ewing's sarcoma; MRI; magnetic resonance imaging; RT-PCR; reverse transcriptase polymerase chain reaction; GFAP; glial fibrillary acidic protein; EMA; epithelial membrane antigen; EWS/FLI1; oncogenic transcription factor; R
Keywords: IL-12; interleukin 12; GET; gene electrotransfer; CMV; cytomegalovirus; EMA; European medicines agency; ORT; operator-repressor titration; SVEC4-10; murine endothelial cells; HUVEC; human umbilical vein endothelial cells; L929; murine fibroblasts; LPB;
Keywords: Yessotoxin; Immune system; Leukocyte; Cytokine; Spleen; Apoptosis; CRM; certified reference material; DAB+; diaminobenzidine; DMSO; dimethyl sulfoxide; DPX; di-n-butyl phthalate in xylene; EMA; European Medicines Agency; HCT; haematocrit; H&E; haematoxyli
Keywords: ADD; attention deficit disorder; ADHD; Attention deficit hyperactivity syndrome; AEDs; antiepileptic drugs; b/p; blood-to-plasma ratio; CBZ; carbamazepine; CI; confidence interval; DBS; dried blood spots; EMA; European Medicines Agency; HCT; hematocrit; L
Keywords: EAH; eating in the absence of hunger; EMA; ecological momentary assessment; SCID-I/P; Structured Clinical Interview for DSM-IV Axis I Disorders/Patient Edition; PANAS; Positive and Negative Affect Schedule; Eating in the absence of hunger; Disinhibited ea
Keywords: 5-FU; 5-fluorouracil; CEA; carcinoembryonic antigen; CYP3A4; cytochrome 3A4; DPD; dihydropyrimidine dehydrogenase; ECOG; Eastern Cooperative Oncology Group; EGFR; epidermal growth factor receptor; EMA; European Medicines Agency; FDA; Food and Drug Adminis
Keywords: AAA; anti-actin antibodies; anti-tTG; anti-tissue transglutaminase; CD; celiac disease; ELISA; enzyme-linked immunosorbent assay; EMA; endomysium antibodies; GFD; gluten-free diet; HLA; human leukocyte antigen; IECs; intestinal epithelial cells; IELs; int
Keywords: A1PI; Virus; Prions; Safety; Purity; Stability; ADA; anti-drug antibody; A1PI; alpha1-proteinase inhibitor; B19V; parvovirus B19; BVDV; bovine viral diarrhea virus; CJD; Creutzfeldt-Jakob-Disease; CPV; canine parvovirus; DTT; dithiothreitol; EMA; European
Keywords: ILD; intensive longitudinal data; EMA; ecological momentary assessment; Dynamical modeling for smoking cessation study; Dynamical systems models; Smoking cessation treatment; Intensive longitudinal data; Withdrawal;
Keywords: SCZ; schizophrenia; HC; healthy control; NMR; nuclear magnetic resonance; CI; confidence interval; OR; odds ratio; PANSS; Positive and Negative Syndrome Scale; SCID; Structured Clinical Interview for DSM Disorders; DSM; Diagnostic and Statistical Manual o
Keywords: clinical presentation; screening; symptoms; villous atrophy; celiac antibodies; follow-up; gluten-free diet; EmA; Endomysial antibody; Rf; Reference value; T1DM; Type 1 diabetes mellitus; TG2ab; Transglutaminase 2 antibody;